StockData
AKANNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31

AKANDA CORP.

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Jun 9, 2026
$1.12−0.08 (-6.67%)

Close on Oct 19, 2026

Market cap
–
P/E (TTM)
–
Dividend yield
–

AKANDA CORP. revenue by segment

No segment breakdown reported

Akanda does not break out revenue by segment, region or product in the tagged data of its filings for this period type.